The evaluation of 186Re-labeled antibodies using N2S4 chelate in vitro and in vivo using tumor-bearing nude mice

A. Najafi, M. M. Alauddin, A. Sosa, G. Q. Ma, D. C.P. Chen, A. L. Epstein, M. E. Siegel

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

We have recently described a method for radiolabeling monoclonal antibodies, with metallic radionuclides using a new chelating agent N2S3. Using this chelate the monoclonal antibodies Lym-1 and B72.3 were labeled with 186Re and their biological integrity was evaluated in vitro and in vivo. 186Re-labeled antibodies using N2S4 methodology were found to be stable in human serum and retained their immunoreactivity. Intravenous administration of 0.5 mCi 186Re-labeled antibodies resulted in partial or complete regression of tumor tissue in mice.

Original languageEnglish (US)
Pages (from-to)205-212
Number of pages8
JournalInternational Journal of Radiation Applications and Instrumentation.
Volume19
Issue number2
DOIs
StatePublished - Feb 1992

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'The evaluation of 186Re-labeled antibodies using N2S4 chelate in vitro and in vivo using tumor-bearing nude mice'. Together they form a unique fingerprint.

Cite this